Computational drug repurposing for viral infectious diseases: a case study on monkeypox

Area of Science:

• Computational biology
• Virology
• Drug discovery

Background:

• Traditional drug repurposing has been vital for identifying antiviral compounds and therapeutic targets.
• Rapid response to emerging infectious diseases necessitates efficient drug discovery strategies.
• Existing computational methods offer powerful tools for analyzing complex biological data.

Purpose of the Study:

• To provide an overview of modern computational methods applied to drug repurposing for viral infections.
• To explore the utilization of diverse datasets, including host response and molecular interaction networks.
• To assess the benefits and limitations of computational drug repurposing using monkeypox as a case study.

Main Methods:

• Leveraging large-scale datasets encompassing host-pathogen interactions and drug responses.
• Analyzing gene expression patterns and protein-protein interaction networks.
• Applying computational models to identify potential drug candidates for viral diseases.

Main Results:

• Computational drug repurposing facilitates the identification of novel antiviral therapies.
• Integration of multi-omics data enhances the accuracy of predicting drug efficacy.
• The study highlights the potential of these methods for rapid deployment against emerging viral threats.

Conclusions:

• Modern computational approaches significantly enhance the efficiency and speed of drug repurposing for viral diseases.
• The insights gained from analyzing complex biological networks are crucial for therapeutic development.
• This methodology, exemplified by monkeypox, offers a scalable framework applicable to various viral infectious scenarios.